S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CAH Cardinal Health Inc

98.79

-4.19 (-4.07%)

Last Updated: 11:50:28

Delayed by 15 minutes

Cardinal Health announces FDA approval of LYMPHOSEEK for use in children

To read the full story on Seeking Alpha, click here.

Cardinal Health (NYSE:CAH)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Cardinal Health Charts.

Cardinal Health (NYSE:CAH)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Cardinal Health Charts.

Cardinal Health Inc News

Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
Thursday 2 May 2024 (1 day ago) • PR Newswire (US)

Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
Monday 22 April 2024 (2 weeks ago) • PR Newswire (US)

Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
Tuesday 26 March 2024 (1 month ago) • PR Newswire (US)

Cardinal Health announces approved science-based climate targets; expands focus across the supply chain
Friday 15 March 2024 (2 months ago) • PR Newswire (US)

Form 3 - Initial statement of beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Cardinal Health annual research report examines milestone year in biosimilars
Thursday 29 February 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Bob Azelby to join Cardinal Health Board of Directors
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

More Cardinal Health Inc News Articles

RespireRx Pharmaceuticals (PK)

Global Developments (PK)

Voip Pal Com (QB)

MicroCloud Hologram

Brookmount Explorations (PK)

Globestar Therapeutics (PK)

Bell Buckle (PK)

NaturalShrimp (QB)

Moon Equity (PK)

BlackStar Enterprise (PK)

Yuenglings Ice Cream (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions